121 related articles for article (PubMed ID: 34767153)
1. RPTOR methylation in the peripheral blood and breast cancer in the Chinese population.
Yin Y; Lei S; Li L; Yang X; Yin Q; Xu T; Zhou W; Li H; Gu W; Ma F; Yang R; Zhang Z
Genes Genomics; 2022 Apr; 44(4):435-443. PubMed ID: 34767153
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of RPTOR in peripheral blood is associated with very early-stage lung cancer.
Zhu Q; Qiao R; Di F; Song Y; Zhang J; Xu T; Wang Y; Dai L; Gu W; Han B; Yang R
Clin Chim Acta; 2022 Dec; 537():173-180. PubMed ID: 36332669
[TBL] [Abstract][Full Text] [Related]
4. [Peripheral blood
Zhou X; Lei S; Li L; Xu T; Gu W; Ma F; Yang R
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1456-1463. PubMed ID: 34755660
[TBL] [Abstract][Full Text] [Related]
5. The association between
Li J; Zhou X; Li L; Ji L; Li J; Qu Y; Wang Z; Zhao Y; Zhang J; Liang F; Liu J; Gu W; Yang R; Ma F; Dai L
Front Oncol; 2023; 13():1148635. PubMed ID: 37274256
[TBL] [Abstract][Full Text] [Related]
6. The association between RAPSN methylation in peripheral blood and breast cancer in the Chinese population.
Lei S; Li L; Yang X; Yin Q; Xu T; Zhou W; Gu W; Ma F; Yang R
J Hum Genet; 2021 Nov; 66(11):1069-1078. PubMed ID: 33958711
[TBL] [Abstract][Full Text] [Related]
7. The Association Between Breast Cancer and Blood-Based Methylation of
Liu C; Zhou X; Jin J; Zhu Q; Li L; Yin Q; Xu T; Gu W; Ma F; Yang R
Front Genet; 2022; 13():927519. PubMed ID: 35812748
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
[TBL] [Abstract][Full Text] [Related]
9. The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies.
Yang R; Stöcker S; Schott S; Heil J; Marme F; Cuk K; Chen B; Golatta M; Zhou Y; Sutter C; Wappenschmidt B; Schmutzler R; Bugert P; Qu B; Bartram CR; Sohn C; Schneeweiss A; Burwinkel B
Carcinogenesis; 2017 Mar; 38(3):312-320. PubMed ID: 28426874
[TBL] [Abstract][Full Text] [Related]
10. The Association Between Breast Cancer and Blood-Based Methylation of
Yin Q; Yang X; Li L; Xu T; Zhou W; Gu W; Ma F; Yang R
Front Genet; 2020; 11():977. PubMed ID: 33005177
[TBL] [Abstract][Full Text] [Related]
11.
Zang Z; Yin Y; Liu C; Zhu Q; Huang X; Li H; Yang R
Epigenetics; 2024 Dec; 19(1):2352683. PubMed ID: 38723244
[TBL] [Abstract][Full Text] [Related]
12. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
14. Methylation of progesterone receptor isoform A promoter in normal breast tissue: An epigenetic link between early age at menarche and risk of breast cancer?
Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Nariman-Saleh-Fam Z; Bastami M; Saadatian Z; Zendehbad Z; Tavakkoly-Bazzaz J
J Cell Biochem; 2019 Aug; 120(8):12393-12401. PubMed ID: 30816620
[TBL] [Abstract][Full Text] [Related]
15. Blood-based DNA methylation as biomarker for breast cancer: a systematic review.
Tang Q; Cheng J; Cao X; Surowy H; Burwinkel B
Clin Epigenetics; 2016; 8():115. PubMed ID: 27895805
[TBL] [Abstract][Full Text] [Related]
16. Association of BLCA-4 hypomethylation in blood leukocyte DNA and the risk of bladder cancer in a Chinese population.
Ji HX; Zhao Q; Pan JH; Shen WH; Chen ZW; Zhou ZS
Pathol Oncol Res; 2013 Apr; 19(2):205-10. PubMed ID: 23055020
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of leukocyte DNA methylation and biomarkers for cancer risk in older adults.
Bartlett AH; Liang JW; Sandoval-Sierra JV; Fowke JH; Simonsick EM; Johnson KC; Mozhui K
Biomark Res; 2019; 7():10. PubMed ID: 31149338
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation of ABCG1 in peripheral blood as a potential marker for the detection of coronary heart disease.
Jin J; Zhao X; Zhu C; Li M; Wang J; Fan Y; Liu C; Shen C; Yang R
Clin Epigenetics; 2023 Jul; 15(1):120. PubMed ID: 37507725
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic modifications of adiponectin gene: Potential association with breast cancer risk.
Pasha HF; Mohamed RH; Toam MM; Yehia AM
J Gene Med; 2019 Oct; 21(10):e3120. PubMed ID: 31415715
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of expression level and methylation profile of
Mohammadi Z; Azad M; Foroughi F; Khojastehpour S; Gheibi N; Samiee-Rad F; Maali A; Ahmadi MH
J Cancer Res Ther; 2021; 17(6):1328-1334. PubMed ID: 34916361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]